ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.37C>T (p.Arg13Cys) (rs141586345)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000165494 SCV000216225 uncertain significance Hereditary cancer-predisposing syndrome 2018-03-29 criteria provided, single submitter clinical testing Insufficient or conflicting evidence
Invitae RCV000230359 SCV000282942 uncertain significance Ataxia-telangiectasia syndrome 2019-10-23 criteria provided, single submitter clinical testing This sequence change replaces arginine with cysteine at codon 13 of the ATM protein (p.Arg13Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs141586345, ExAC 0.01%). This variant has been reported in the literature in individuals with breast cancer (PMID: 10677309, 17393301, 19781682). ClinVar contains an entry for this variant (Variation ID: 185977). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000589373 SCV000293426 uncertain significance not provided 2018-01-30 criteria provided, single submitter clinical testing This variant is denoted ATM c.37C>T at the cDNA level, p.Arg13Cys (R13C) at the protein level, and results in the change of an Arginine to a Cysteine (CGT>TGT). This variant has been observed in at least two women with breast cancer (Broeks 2000, Broeks 2008, Tavtigian 2009). ATM Arg13Cys was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is not located in a known functional domain. In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect. Based on currently available evidence, it is unclear whether ATM Arg13Cys is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Integrated Genetics/Laboratory Corporation of America RCV000589373 SCV000694265 uncertain significance not provided 2015-10-05 criteria provided, single submitter clinical testing
Counsyl RCV000230359 SCV000792114 uncertain significance Ataxia-telangiectasia syndrome 2017-06-08 criteria provided, single submitter clinical testing
Color RCV000165494 SCV000911423 uncertain significance Hereditary cancer-predisposing syndrome 2019-04-03 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.